|
AMT-116 Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 1: 1Phase 1/2: 1
Top Sponsors
- Multitude Therapeutics Inc.2
Indications
- Cancer2
- Advanced Solid Tumors1
- Advanced Solid Tumor1
Other1 trial
Denver, Colorado1 trial
AMT-116 in Patients With Advanced Solid Tumors
Sarah Cannon Research Institute
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.